Global Director Financial Controls
Parsippany, Nj, Us
On behalf of Senior Executives, I led the global implementation of internal controls over financial reporting (SOX) post separation from Pfizer and through a successful external audit. Managed a team of internal colleagues and global consultants during the SOX implementation and initial compliance testing activities, which occurred during a complex period of rapid change, including financial systems migrations, turnover in key personnel, transactional service agreements and the migration of shared service centers. Highlights of the position were as follows: -Worked directly with Pfizer’s Financial Reporting teams to obtain certifications regarding the accuracy of the ‘Carve-Out’ financial statements for Zoetis. Continuously accessed materiality and scoping due to rapid business changes.-In March 2013, during the first annual Finance Directors’ Conference, I presented the SOX project plan and introduced the project team to Senior Executives, including the CEO, CFO, CIO and over 90 Finance Directors.-Designed and implemented the quarterly SOX 302 certification and sub-certification structures and procedures.-Led and worked closely with several colleagues across multiple departments to implement the SOX infrastructure.-Key member of the team that selected a third-party consulting firm to assist with the global documentation and testing phase, especially in certain foreign language locations, for example, China and Japan.-Provided quarterly SOX updates directly to the Audit Committee and addressed their questions.-Researched and presented an initial approach for use in transitioning the company to COSO-2013.-Managed the SOX implementation and compliance budgets, including tracking invoices and expenses.Key accomplishments: SOX was successful implemented and passed review by the external auditors in March 2015, with no material weaknesses. SOX compliance procedures and activities were fully stabilized as I exited the company in 2016.